Vault-13

Edwards Lifesciences C

COM · CUSIP 26176E108

0 institutional holders -1 vs Q1 2022
—reported value*
0 new 0 added 0 reduced 1 sold out net sold ≈ $7.0k (-60 shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.

Trends to Q2 2022

Institutional holders

Managers reporting a position, each quarter

012Q4 19: 2Q1 20: 1Q2 20: 1Q3 20: 1Q4 20: 0Q1 21: 0Q2 21: 0Q3 21: 1Q4 21: 1Q1 22: 1Q2 22: 00Q4 19Q2 20Q4 20Q2 21Q4 21Q2 22
Numbers
QuarterHolders
Q4 20192
Q1 20201
Q2 20201
Q3 20201
Q4 20200
Q1 20210
Q2 20210
Q3 20211
Q4 20211
Q1 20221
Q2 20220

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
101Q1 20: 1 bought or addedQ1 20: 1 cut or sold outQ1 20Q2 20: 1 bought or addedQ2 20: 1 cut or sold outQ3 20: 0 bought or addedQ3 20: 1 cut or sold outQ3 20Q4 20: 0 bought or addedQ4 20: 1 cut or sold outQ4 21: 0 bought or addedQ4 21: 0 cut or sold outQ4 21Q1 22: 0 bought or addedQ1 22: 0 cut or sold outQ2 22: 0 bought or addedQ2 22: 1 cut or sold outQ2 22
Numbers
QuarterBought or addedCut or sold out
Q1 202011
Q2 202011
Q3 202001
Q4 202001
Q4 202100
Q1 202200
Q2 202201

Biggest buyers

None

Biggest sellers

AlphaMark Advisors, LLC Sold out -60-60

Holders, Q2 2022

#ManagerLocationShares Value% of their portfolioChangeShares change